Embecta Corp (EMBC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Embecta Corp (EMBC) has a cash flow conversion efficiency ratio of -0.050x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($31.10 Million) by net assets ($-626.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Embecta Corp PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Embecta Corp - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Embecta Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. See shareholders equity of Embecta Corp for net asset value and shareholders' equity analysis.
Embecta Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Embecta Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bleichroeder Acquisition Corp. I Class A Ordinary Shares
NASDAQ:BACQ
|
0.000x |
|
Embention Sistemas Inteligentes S.A.
PA:MLUAV
|
N/A |
|
Gia Lai Electricity JSC
VN:GEG
|
0.076x |
|
Samyoung Elec
KO:005680
|
0.016x |
|
Oriental Interest Bhd
KLSE:5827
|
0.004x |
|
AMIA Co. Ltd.
TW:8438
|
0.062x |
|
J.Jill Inc
NYSE:JILL
|
-0.013x |
|
BINEX Co. Ltd
KQ:053030
|
0.019x |
Annual Cash Flow Conversion Efficiency for Embecta Corp (2019–2025)
The table below shows the annual cash flow conversion efficiency of Embecta Corp from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Embecta Corp market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $-651.20 Million | $191.70 Million | -0.294x | -508.80% |
| 2024-09-30 | $-738.30 Million | $35.70 Million | -0.048x | +41.31% |
| 2023-09-30 | $-821.70 Million | $67.70 Million | -0.082x | +82.18% |
| 2022-09-30 | $-891.40 Million | $412.20 Million | -0.462x | -160.24% |
| 2021-09-30 | $594.00 Million | $456.00 Million | 0.768x | -11.91% |
| 2020-09-30 | $572.00 Million | $498.50 Million | 0.872x | +6.82% |
| 2019-09-30 | $619.00 Million | $505.00 Million | 0.816x | -- |
About Embecta Corp
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors… Read more